AQST
Aquestive Therapeutics, Inc.
NASDAQ · USHealthcareDrug Manufacturers - Specialty & Generic
$3.94-4.25%
Price as of Jul 20, 2026
AQST capital
Aquestive Therapeutics, Inc. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- -3.92x
- Net debt / equity
- -0.67x
- Debt / assets
- 0.95x
- Debt / EBITDA
- -2.59x
- Net debt / EBITDA
- -0.44x
Liquidity & coverage
- Current ratio
- 4.10x
- Quick ratio
- 3.85x
- Cash ratio
- 3.49x
- Interest coverage
- -3.34x
- EBITDA / interest
- -3.08x
- Working capital
- $98.4M
Cash & dividend
- FCF / debt
- -0.33x
- Cash flow / debt
- -0.33x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.